Evidence map›Paper›PMID 26678062›Full record

ReviewExpert review of respiratory medicine2016

Toll-like receptors, triggering receptor expressed on myeloid cells family members and receptor for advanced glycation end-products in allergic airway inflammation.

Sannette C Hall, Devendra K Agrawal

Open access · greenAbstract readReview
In one paragraph

Review in Expert review of respiratory medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. AXL Inhibits Proinflammatory Factors to Relieve Rheumatoid Arthritis Pain by Regulating the TLR4/NF-Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  10. Article
  11. TLR7/8 in the Pathogenesis of Parkinson's Disease.International journal of molecular sciences · 2020
    Article
  12. Review
  13. TREM-1; Is It a Pivotal Target for Cardiovascular Diseases?Journal of cardiovascular development and disease · 2018
    Review
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sannette C Halla Department of Biomedical Science , Creighton University School of Medicine , Omaha , NE , USA.
Devendra K Agrawala Department of Biomedical Science , Creighton University School of Medicine , Omaha , NE , USA.
Creighton University · US

Funding

MESENCHYMAL STEM CELLS IN THE PREVENTION OF THROMBOSIS AND NEOINTIMAL HYPERPLASIAR01HL112597 · NHLBI · CREIGHTON UNIVERSITY · PI AGRAWAL, DEVENDRA K. · 2012 to 2016
$3.8M
EPICARDIAL ADIPOSE TISSUE, OBESITY AND INFLAMMATION IN ATHEROSCLEROSISR01HL120659 · NHLBI · CREIGHTON UNIVERSITY · PI AGRAWAL, DEVENDRA K. · 2013 to 2017
$3.6M
TGF-BETA, CHLORIDE CHANNELS AND MIGRATION OF EOSINOPHILSR01AI075315 · NIAID · CREIGHTON UNIVERSITY · PI AGRAWAL, DEVENDRA K. · 2008 to 2012
$1.8M
FLT3-LIGAND, IMMUNOMODULATION AND THERAPY IN ASTHMAR01HL070885 · NHLBI · CREIGHTON UNIVERSITY · PI AGRAWAL, DEVENDRA K. · 2004 to 2008
$1.1M
TGF-BETA, CHLORIDE CHANNELS AND APOPTOSIS OF AIRWAY EPITHELIAL CELLSR01HL085680 · NHLBI · CREIGHTON UNIVERSITY · PI AGRAWAL, DEVENDRA K. · 2009 to 2010
$874k
NHLBI NIH HHS R01 HL070885NHLBI NIH HHS R01 HL085680NHLBI NIH HHS R01HL085680NHLBI NIH HHS R01 HL112597NHLBI NIH HHS R01 HL120659NIAID NIH HHS R01 AI075315
6 · The paper itself

Abstract

Asthma is a chronic disorder of the airways characterized by cellular infiltration, airway hyper-responsive and airway inflammation. Innate immune cells are the first line of defense against endogenous and exogenous signals in the airways and as such possess a diverse array of pattern recognition receptors. Toll-like receptors are crucial sentinels which when activated, can either promote or ameliorate the inflammatory response in predisposed individuals. The recently discovered triggering receptor expressed on myeloid cells family members are emerging mediators of inflammation. These receptors are believed to modulate inflammatory responses by collaborating with classic PRRs. Endogenous signals like HMGB-1, signaling through the receptor for advanced glycation end products, also promotes inflammation, however, its contribution to inflammation in the airways is not well known. Here, we discuss the role of each receptor in airway inflammation and highlight potential synergistic mechanisms, which contribute to disease pathogenesis in allergic asthma.

Indexed as

AnimalsAsthmaGlycation End Products, AdvancedHumansInflammationMyeloid CellsReceptor for Advanced Glycation End ProductsToll-Like ReceptorsGlycation End Products, AdvancedReceptor for Advanced Glycation End ProductsToll-Like ReceptorsAllergic airway inflammationasthmaDAP12HMGB-1NF-κBRAGETLRTREM

Identifiers

PMID26678062
PMCPMC4955846
OpenAlexW2207465203

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.